The study, led by researchers at the Washington, D.C.-based Urban Institute and Boston-based Harvard T.H. Chan School of Public Health, compared financial audit data from 156 health systems in 2018.
The researchers found that a 1-unit increase in the ratio for commercial payer to Medicare prices for inpatient services led to a 21.3 percent increase in days of cash on hand and a 2.7 percentage point increase in operating margins.
The study’s findings “provide evidence against the claim that relatively higher commercial prices are primarily used to offset losses from public payers rather than to increase profits and liquidity,” the authors wrote.
Read the full study here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
